Menu

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1105)

Company Market Cap Price
DXCM DexCom, Inc.
DexCom's core product is continuous glucose monitoring (CGM), i.e., glucose monitoring devices sold as CGM systems.
$24.52B
$62.53
+1.36%
WAT Waters Corporation
Waters supplies diagnostic instruments used in laboratories for analytical testing and qualification workflows.
$24.23B
$407.44
-1.24%
PODD Insulet Corporation
Insulet's core business is medical devices and equipment, anchored by the Omnipod insulin pump platform.
$23.00B
$326.89
-0.60%
LH Labcorp Holdings Inc.
Labcorp offers liquid biopsy tests (e.g., MRD portfolios) as part of its oncology testing portfolio.
$22.29B
$268.36
-0.28%
UTHR United Therapeutics Corporation
Tyvaso DPI and Remunity Pump are medical devices for drug delivery, reflecting UTHR's device-based delivery platforms.
$22.09B
$488.57
+0.58%
DGX Quest Diagnostics Incorporated
Quest provides laboratory testing services and advisory/regulatory support for microbiology and analytical workflows.
$21.21B
$189.74
-1.36%
CHD Church & Dwight Co., Inc.
Waterpik dental water flossers and related oral-care devices are dental equipment products.
$20.60B
$84.56
+0.48%
WST West Pharmaceutical Services, Inc.
West designs and manufactures medical devices and delivery systems (e.g., autoinjectors, prefilled syringes).
$19.93B
$277.31
-1.26%
ZBH Zimmer Biomet Holdings, Inc.
Zimmer Biomet's core orthopedic devices business centers on joint implants (hips and knees) and related prosthetics.
$19.32B
$97.59
+0.54%
THC Tenet Healthcare Corporation
Tenet operates hospitals and hospital-based care delivering inpatient and outpatient services.
$19.21B
$217.63
-0.38%
EXAS Exact Sciences Corporation
Exact Sciences’ pipeline includes blood-based cancer diagnostics (liquid biopsy) such as Oncodetect MRD and blood-based CRC test programs, making Liquid Biopsy a core product category.
$19.21B
$101.44
+0.31%
ULS UL Solutions Inc.
UL Solutions offers Laboratory Testing & Advisory Services, including regulatory advisory and compliance support.
$18.11B
$90.16
+1.67%
SNA Snap-on Incorporated
RS&I segment includes diagnostic equipment and repair information software platforms.
$17.76B
$340.64
+0.10%
MEDP Medpace Holdings, Inc.
Provides Laboratory Testing & Advisory Services including bio-analytical labs and regulatory support as a CRO service.
$17.04B
$606.27
-0.91%
HOLX Hologic, Inc.
Panther Panther Fusion molecular diagnostics platform and Aptima/BV/CV/TV assays are diagnostic equipment sold by Hologic.
$16.64B
$74.80
-0.11%
COO The Cooper Companies, Inc.
CooperVision and CooperSurgical primarily manufacture ophthalmology devices and related vision-care products, fitting Ophthalmology Devices.
$15.55B
$77.94
-0.35%
UHS Universal Health Services, Inc.
UHS directly provides hospital inpatient and related acute care services.
$15.54B
$244.17
+0.18%
SOLV Solventum Corporation
V.A.C. Peel and Place dressing is a wound care device, a core MedSurg product.
$14.78B
$85.38
-0.46%
ROIV Roivant Sciences Ltd.
Auto-injector devices enabling at-home administration for IMVT-1402, fitting Auto-Injector Devices.
$14.25B
$20.86
+0.02%
FMS Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care manufactures and provides Blood Purification Devices used in dialysis, including the 5008X CAREsystem.
$13.98B
$23.83
-0.96%
NDSN Nordson Corporation
Atrion's medical components and medical device technologies place Nordson in the medical devices & biometrics space.
$13.45B
$238.07
-0.11%
GH Guardant Health, Inc.
Core product category: Guardant Health's liquid biopsy tests (Guardant360 Liquid/Tissue) are the primary offerings.
$13.44B
$107.80
-0.93%
TEM Tempus AI, Inc.
Laboratory Testing & Advisory Services – Tempus provides outsourced laboratory testing and regulatory/advisory support.
$13.41B
$77.20
+0.47%
GMED Globus Medical, Inc.
Orthopedic devices and implants (spinal, ALIF spacers, knee systems) sold for reconstruction.
$12.30B
$91.05
-0.14%
RVTY Revvity, Inc.
Revvity's Diagnostics segment includes diagnostic equipment and instruments.
$12.15B
$104.66
-0.87%
EHC Encompass Health Corporation
Encompass Health operates inpatient rehabilitation hospital services, aligning with the Hospital Services investable theme.
$11.71B
$116.27
+0.07%
PEN Penumbra, Inc.
Penumbra's core offerings include vascular intervention devices used for thrombectomy and catheter-based clot removal.
$11.54B
$295.93
-0.93%
QGEN Qiagen N.V.
QIAGEN directly manufactures diagnostic instruments (e.g., QIAstat-Dx, QIAcuity, QIAsymphony Connect) and automated platforms.
$10.77B
$48.10
-0.95%
ALGN Align Technology, Inc.
Align's Invisalign system, iTero scanners, and direct 3D-printed dental devices are core dental equipment products.
$10.67B
$147.22
-0.19%
TECH Bio-Techne Corporation
Medical device consumables are used with Bio-Techne's instruments and reagents, contributing recurring revenue.
$10.05B
$64.60
-1.90%
BAX Baxter International Inc.
Novum IQ infusion platform is a medical device platform core to Baxter's Medical Devices & Equipment offerings.
$9.71B
$18.91
+1.31%
HSIC Henry Schein, Inc.
Henry Schein directly distributes dental equipment to dental practices, aligning with its core product offerings.
$9.13B
$75.27
-0.31%
BIO Bio-Rad Laboratories, Inc.
Bio-Rad directly manufactures and sells diagnostic instruments and related equipment used in clinical laboratories.
$8.85B
$327.17
-1.52%
CRL Charles River Laboratories International, Inc.
CRL offers outsourced laboratory testing and advisory/regulatory support services in non-clinical research and safety testing.
$8.81B
$178.98
+0.52%
HIMS Hims & Hers Health, Inc.
Laboratory testing & advisory services core to in-house lab capabilities.
$8.68B
$38.41
+3.55%
DVA DaVita Inc.
DaVita provides outpatient dialysis clinics and related kidney care services, aligning with hospital/healthcare services in a medical facility setting.
$8.59B
$120.13
-1.02%
HALO Halozyme Therapeutics, Inc.
Halozyme is expanding its portfolio of auto-injector devices to enable at-home/self-administration of therapies.
$8.50B
$72.68
-0.19%
ATR AptarGroup, Inc.
Aptar supplies medical devices/equipment relevant to pharma and healthcare, including device components and sterilization tech.
$8.16B
$123.82
+0.31%
AVTR Avantor, Inc.
Avantor provides Laboratory Testing & Advisory Services, aligning with outsourced testing and regulatory support offerings.
$8.00B
$11.74
-0.93%
MASI Masimo Corporation
Primary revenue comes from patient monitoring devices and systems sold to healthcare providers.
$7.82B
$143.94
-1.74%
← Previous
1 2 3 4 ... 12
Next →
Showing page 2 of 12 (1105 total stocks)

Loading company comparison...

Loading research report...

EHC Encompass Health Corporation

Encompass Health and Vanderbilt Health Announce 40‑Bed Rehabilitation Hospital in Lebanon, Tennessee

Nov 25, 2025
HSIC Henry Schein, Inc.

Henry Schein One Unveils Voice‑Workflow and AI Suite for Dentrix Platforms

Nov 25, 2025
EHC Encompass Health Corporation

Encompass Health Announces 50‑Bed Rehabilitation Hospital in Fishers, Indiana, Expanding Its Largest U.S. Network

Nov 21, 2025
LH Labcorp Holdings Inc.

Labcorp’s Plasma Detect MRD Assay Validated in Two High‑Impact Oncology Studies

Nov 21, 2025
DXCM DexCom, Inc.

DexCom Secures FDA Clearance for Smart Basal, Expanding Type 2 Diabetes Portfolio

Nov 20, 2025
SOLV Solventum Corporation

Solventum to Acquire Acera Surgical for $850 Million, Expanding Advanced Wound‑Care Portfolio

Nov 20, 2025
BAX Baxter International Inc.

Baxter Launches Tender Offers to Repurchase 2026 and 2027 Senior Unsecured Notes, Strengthening Balance Sheet

Nov 19, 2025
QGEN Qiagen N.V.

Qiagen and CellBxHealth Announce Co‑Marketing Partnership to Expand Liquid Biopsy Solutions

Nov 18, 2025
MASI Masimo Corporation

Masimo Secures $634 Million Verdict Against Apple Over Blood‑Oxygen Patent

Nov 15, 2025
TEM Tempus AI, Inc.

Tempus AI Announces First Nonprofit Collaboration to Build Multi‑Omic Follicular Lymphoma Dataset

Nov 14, 2025
ZBH Zimmer Biomet Holdings, Inc.

Zimmer Biomet Receives FDA Clearance for Enhanced ROSA Knee with OptimiZe System

Nov 14, 2025
HIMS Hims & Hers Health, Inc.

Hims & Hers Launches At‑Home Lab Testing Service, Expanding Digital Health Platform

Nov 13, 2025
DXCM DexCom, Inc.

DexCom Announces Strategic Partnership with Carrot and ŌURA to Expand Metabolic‑Fertility Insights

Nov 12, 2025
GH Guardant Health, Inc.

Guardant Health Launches Single Namespace Working Group to Standardize Exabyte‑Scale Data Access

Nov 12, 2025
HOLX Hologic, Inc.

Hologic Expands CE Marking for Genius Digital Diagnostics System to Include Tissue Specimens

Nov 12, 2025
EHC Encompass Health Corporation

Encompass Health Opens 50‑Bed Rehabilitation Hospital in Amarillo, Texas, Expanding Texas Footprint

Nov 11, 2025
GH Guardant Health, Inc.

Guardant Health Expands Guardant Reveal to Monitor Late‑Stage Therapy Response

Nov 10, 2025
RVTY Revvity, Inc.

Revvity to Acquire ACD/Labs for $70 Million, Expanding Signals Software Capabilities

Nov 10, 2025
GMED Globus Medical, Inc.

Globus Medical Beats Q3 2025 Earnings, Raises Full‑Year Guidance on Strong Spine and Nevro Growth

Nov 07, 2025
SOLV Solventum Corporation

Solventum Reports Q3 2025 Earnings: Revenue Beats Estimates, Adjusted EPS Misses Forecasts, Guidance Raised

Nov 07, 2025
HSIC Henry Schein, Inc.

Henry Schein One Launches Impact Panel, Integrating AI‑Driven Patient Education into Dentrix Platforms

Nov 06, 2025
PEN Penumbra, Inc.

Penumbra Reports Q3 2025 Earnings: Revenue and EPS Beat Estimates, Guidance Raised

Nov 06, 2025
PODD Insulet Corporation

Insulet Reports Q3 2025 Earnings: EPS and Revenue Beat Expectations, Guidance Raised

Nov 06, 2025
GH Guardant Health, Inc.

Guardant Health Upsizes Convertible Notes and Common Stock Offering to Raise $623.5 Million

Nov 05, 2025
MASI Masimo Corporation

Masimo Reports Strong Q3 2025 Earnings: Revenue Up 8.2%, EPS Beats Estimates by 38%, and Operating Margin Expands 450 Basis Points

Nov 05, 2025
QGEN Qiagen N.V.

QIAGEN Reports Q3 2025 Earnings, Raises Guidance, Announces Parse Acquisition and Share Repurchase

Nov 05, 2025
TEM Tempus AI, Inc.

Tempus AI Reports Q3 2025 Earnings: Revenue Beats, First Positive Adjusted EBITDA, Guidance Raised

Nov 05, 2025
ZBH Zimmer Biomet Holdings, Inc.

Zimmer Biomet Reports Q3 2025 Earnings: EPS Beats Estimates, Revenue Misses Slightly

Nov 05, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Reports Strong Q3 2025 Earnings, Beats Guidance

Nov 04, 2025
HIMS Hims & Hers Health, Inc.

Hims & Hers Health Reports Q3 2025 Earnings, Narrows Full‑Year Guidance, and Continues Wegovy Discussions

Nov 04, 2025
HSIC Henry Schein, Inc.

Henry Schein Reports Record Q3 2025 Sales, Raises Full‑Year Guidance

Nov 04, 2025
THC Tenet Healthcare Corporation

Tenet Secures $2.25 Billion Private Placement to Refine Debt Structure

Nov 04, 2025
BAX Baxter International Inc.

Baxter International Faces Securities Fraud Class Action Over Novum LVP Defects

Oct 31, 2025
ALGN Align Technology, Inc.

Align Technology Reports Q3 2025 Earnings: Revenue Near $1 Billion, Guidance Holds at $1.04 Billion for Q4

Oct 30, 2025
BAX Baxter International Inc.

Baxter Reports Q3 2025 Earnings, Adjusted EPS Guidance $2.35-$2.40

Oct 30, 2025
BIO Bio-Rad Laboratories, Inc.

Bio‑Rad Reports Q3 2025 Results: Revenue Up 0.5%, Net Loss Due to Fair‑Value Adjustment

Oct 30, 2025
DXCM DexCom, Inc.

DexCom Reports Strong Q3 2025 Results, Raises Full‑Year Guidance

Oct 30, 2025
EHC Encompass Health Corporation

Encompass Health Reports Strong Q3 2025 Earnings, Raises Full‑Year Guidance

Oct 30, 2025
HOLX Hologic, Inc.

Hologic Acquisition by Blackstone and TPG Expected to Close in First Half of 2026

Oct 22, 2025
HOLX Hologic, Inc.

Hologic Agrees to Be Acquired by Blackstone and TPG in Up to $18.3 Billion Deal

Oct 21, 2025
HOLX Hologic, Inc.

Blackstone and TPG Reportedly in Advanced Takeover Talks for Hologic

Oct 20, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Joseph Turk Appointed New Management Board Member and CEO for Care Enablement Segment

Oct 01, 2025
HOLX Hologic, Inc.

Hologic Receives FDA Clearance and CE Mark for Panther Fusion® GI Bacterial Assays

Sep 30, 2025
HOLX Hologic, Inc.

Minicarm.com Named Exclusive U.S. Distributor for Hologic's Fluoroscan® Insight FD Mini C-Arm

Sep 29, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Increases Ownership in Interwell Health, Appoints New Value-Based Care CEO

Sep 18, 2025
HOLX Hologic, Inc.

Blackstone and TPG Revive Interest in Acquiring Hologic

Sep 17, 2025
HOLX Hologic, Inc.

Report Indicates Decline in US STI Testing Sales, Impacting Key Diagnostic Areas

Sep 09, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Initiates First Tranche of €1 Billion Share Buyback Program

Aug 11, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Fresenius Medical Care Delivers Strong Q2 2025 Organic Revenue and Double-Digit Operating Income Growth, Confirms Outlook and Share Buyback Initiation

Aug 05, 2025
FMS Fresenius Medical Care AG & Co. KGaA

Frenova, Fresenius Medical Care's CRO, Collaborates with Azenta Life Sciences and Nephronomics for Genomics Research

Jul 31, 2025

The most compelling investment themes are the ones nobody is talking about yet.

Every Monday, get three under-the-radar themes with catalysts, data, and stocks poised to benefit.

Sign up now to receive them!

Also explore our analysis on 5,000+ stocks